LIPO
Lipella Pharmaceuticals Inc. - Common Stock (LIPO)
$22
About Lipella Pharmaceuticals Inc. - Common Stock (LIPO)
Lipella Pharmaceuticals, Inc. develops and commercializes lipid-based therapies for common bladder syndromes. It offers LP-08 which consists of Sphingomyelin Phospholipid bilayers separated by aqueous compartments, LP-09, a liposomal formulation of Botulinum toxin, and LP-10, a proprietary liposomal formulation of Tacrolimus, a potent immunosuppressant and anti-inflammatory agent. The company was founded by Jonathan Kaufman and Michael Chancellor on February 15, 2005 and is headquartered in Pittsburgh, PA.
Details
Daily high
$0.22
Daily low
$0.22
Price at open
$0.22
52 Week High
$7.31
52 Week Low
$0.21
Market cap
993,500
Dividend yield
0.00%
Volume
6,168
Avg. volume
10,335
P/E ratio
-.09
Lipella Pharmaceuticals Inc. - Common Stock News
Details
Daily high
$0.22
Daily low
$0.22
Price at open
$0.22
52 Week High
$7.31
52 Week Low
$0.21
Market cap
993,500
Dividend yield
0.00%
Volume
6,168
Avg. volume
10,335
P/E ratio
-.09